Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • COVID-19 or DENGUE?

Does the neutrophil level detect the severity of COVID-19?

CNCI JRF Job Openings | Chittaranjan National Cancer Institute

COVID-19 or DENGUE?
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID-19 or DENGUE?

bioxone September 10, 2020September 10, 2020

–Arpita  Adhikary, Amity University Kolkata

When the 21st century is facing pandemic, it is reported that Dengue and coronavirus share almost similar clinical features that cannot be discriminated. There are few independent research studies that observed false-positive tests for coronavirus.

In Singapore, two false-positive results from rapid serological testing for dengue was later confirmed to have COVID-19. 57-year-old man & woman with no medical and travel history got a positive result for dengue but due to bad health, a chest radiograph was done for SARS-CoV-2 via RT-PCR from nasopharyngeal swab, which returned positive.

In CSIR-IICB, five out of thirteen dengue antibody-positive serum samples showed false-positive results in SARS-CoV-2 in 2017. In Israel serum samples of 55 people were taken for SARS-CoV-2 infection, also undergo an ELISA test for assessment of serology status in patients with dengue. After analysis, 12 (21%) positive cases were detected. Though it is not expected to show false positive results as these viruses come from different families so there is a chance of cross-reactivity between dengue and SARS-COVID 19.

Reference:

  • Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist, Himadri Nath, Abinash Mallick, Subrata Roy, Soumi Sukla, Keya Basu, Abhishek De, Subhajit Biswas
    doi: https://doi.org/10.1101/2020.07.03.20145797
  • Covert COVID-19 and false-positive dengue serology in Singapore, Gabriel Yan,a Chun Kiat Lee,b Lawrence T M Lam,c Benedict Yan,b Ying Xian Chua,c Anita Y N Lim,a Kee Fong Phang,a Guan Sen Kew,a Hazel Teng,a Chin Hong Ngai,a Li Lin,d Rui Min Foo,d Surinder Pada,d Lee Ching Ng,e and Paul Anantharajah Tambyaha,Lancet Infect Dis. 2020;20(5):536. doi:10.1016/S1473-3099(20)30158-4,
  • Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses, Yaniv Lustig, Shlomit Keler, Rachel Kolodny,Nir Ben-Tal, Danit Atias-Varon, Ekaterina Shlush, M.D, Motti Gerlic, Ariel Munitz, Ram Doolman, Keren Asraf, Liran I Shlush, M.D., Asaf Vivante, M.D.,,Clinical Infectious Diseases, 2020, ciaa1207, https://doi.org/10.1093/cid/ciaa1207

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged corona Covid CSIR DENGUE False- Positive

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Latest
  • Signaling Pathway

CNCI JRF Job Openings | Chittaranjan National Cancer Institute

bioxone September 10, 2020

–Shristi Sharma, Team bioXone CNCI JRF Job Openings – Chittaranjan National Cancer Institute has called applications for Junior Research Fellow Vacancy. Interested and eligible candidates can check out all of the details on the same below: Advertisement No. 607/2020 A virtual online interview will certainly be held on 25th September 2020, 11 a.m. for two […]

Related Post

  • BiotechToday
  • World

Airborne Pollen hypothesized as ideal COVID-19 carrier

bioxone June 28, 2021June 27, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi The concept of viral infection focuses on the transmission of viral particles from one individual and infecting someone close in contact. Researchers across the globe have created theories to explain the high prevalence of COVID-19 infection from the beginning of the crisis. They discovered that viral particles may […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Facts on how the brain matures.

bioxone June 2, 2021June 2, 2021

Saptaparna Pal, Amity University Kolkata Some researchers from The Virginia School of Medicine have shed new light on how our brains mature; disclosing that the very last step in cell proliferation is important for the brain to reach its actual size and function. The new findings that are published in The Journal of Neuroscience identify […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

High-Grade Serous Ovarian Carcinoma & its radical treatment

bioxone August 7, 2021August 6, 2021

Srabani Roy Chowdhury (MAKAUT, WB) HGSC or High-Grade Serous Ovarian Carcinoma is considered to be an aggressive type of ovarian cancer. Deleterious mutations present in the DNA repair gene RAD51C are drivers of defective homologous recombination in High-Grade Serous Ovarian Carcinoma (HGSC). These are emerging biomarkers of PARP inhibitor sensitivity. A PARP inhibitor is targeted […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy